Loading...
•
Dec 31, 2023
•/
DBV Technologies Q4 2023 Earnings Report
DBV Technologies reported its full year 2023 financial results and business update.
Key Takeaways
DBV Technologies reported cash and cash equivalents of $141.4 million as of December 31, 2023. The company experienced a net loss of $72.7 million for the year ended December 31, 2023. They are focused on completing enrollment in VITESSE, their Phase 3 efficacy and safety trial in children.
Advanced Viaskin™ Peanut clinical development programs in peanut-allergic toddlers (1 through 3 years old) and children (4 through 7 years old).
Strengthened executive leadership team in preparation for BLA submission.
Confirmed EPITOPE study is sufficient for clinical portion of a BLA.
Initiated VITESSE, a Phase 3 clinical trial to evaluate the efficacy and safety of the circular Viaskin Peanut patch in peanut-allergic children aged 4 through 7 years.
Forward Guidance
DBV Technologies anticipates several key events in 2024, including initiating COMFORT Toddlers and COMFORT Children, screening the last patient in VITESSE, and announcing top-line efficacy and safety data from year three of EPITOPE.
Positive Outlook
- Initiate COMFORT Toddlers, the six-month supplemental safety trial in support of BLA.
- Screen last patient in VITESSE, now expected by Q3 2024.
- Initiate COMFORT Children, the six-month supplemental safety trial in support of BLA.
- Announce top-line efficacy and safety data from year three of EPITOPE, corresponding to end-of-study results for participants completing three years of active treatment.
- Publish manuscripts including invited reviews in peer-reviewed scientific journals and submit abstracts on new data at upcoming scientific conferences.
Challenges Ahead
- The Company has incurred operating losses and negative cash flows from operations since inception.
- The Company’s available cash and cash equivalents are not projected to be sufficient to support its operating plan for at least the next 12 months.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...